This EV stock is literally punishing shorts 🥊

Plus NFL partnerships and FDA fast track has these stocks soaring                                                                                                                                                                                                                                                                                                                                                                                                                 *together with (Nasdaq: GAME)  Good morning, 360! Here are our top investing ideas today! And make sure to join us at 1pm EST for an exclusive interview with GameSquare CEO, Justin Kenna in the 360 Wall Street Chatroom —> [join here at 1pm EST.]( MULN - 2nd day play up over 45% in pre-market after closing 68% higher yesterday KZIA - Up over 25% in pre-market after receiving FDA Fast Track Designation for paxalisib GENI - Up over 11% in pre-market after extending partnership with NFL as Exclusive Official Data and Watch & Bet Distribution Partner *A Message on Behalf of GameSquare 🔥 Hot Stock of the Day 🔥 GameSquare Holdings, Inc (NASDAQ: GAME) What a start GameSquare (GAME) had yesterday! We knew it was a good idea, but EVEN we were blown away to see it gain [over 30% in a single day](! [Source: Yahoo! Finance]( And today, in the [360 Wall Street Chat Room](, GameSquare CEO Justin Kenna will be joining us @ 1pm EST! Make sure GAME is on your radar today! And always make sure you take the time to research and understand every investment you make. Get started by visiting GAME’s investor [website]( to learn more. *Sponsored by GameSquare, please see disclosures below MULN - 2nd day play up over 45% in pre-market after closing 68% higher yesterday Mullen Automotive (MULN) is an electric vehicle company that manufactures and distributes electric vehicles. Its products include passenger electric vehicles and commercial vehicles. It also provides solid-state polymer battery technology. Shares of MULN are trading over 45% higher in pre-market on Thursday, after record volume in the prior session. Yesterday, the [company announced]( it has retained Christian Attar, formally known as Christian Levine Law Group, and in partnership with Warshaw, Burstein, LLP, to combat naked short selling activities. Based on [reports]( Mullen has received from ShareIntel, the Company believes it may have been the target of a market manipulation scheme involving illegal naked short selling of its common stock, prompting the CEO and chairman of Mullen Automotive, Inc., David Michery to [state](: “Since our announcement on April 28, we have been actively investigating naked short selling and we now have enough intel to have the law firm actively investigate and, where justified, take action against any market manipulators using naked short selling, spoofing or other illegal acts.” $0.24 has been support so far in the pre-market and will be an important level to watch. Above it, targets to the upside are $0.26, $0.28 and then the pre-market high at $0.2950. Beyond that, $0.40, $0.50, $0.60 and $0.70 come into play. Below $0.24, there is potential support at $0.20, $0.18 and gap to fill at $17.09. KZIA - Up over 25% in pre-market after receiving FDA Fast Track Designation for paxalisib Kazia Therapeutics (KZIA) is an oncology-focused biotechnology company that develops anti-cancer drugs. This morning (KZIA) [announced]( that its lead program, paxalisib, has been awarded Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) for the treatment of solid tumor brain metastases harboring PI3K pathway mutations in combination with radiation therapy. Here are some [Key Points](: - FTD is designed to expedite development of pharmaceutical products which demonstrate the potential to address unmet medical needs in serious or life-threatening conditions. - FTD provides Kazia with enhanced access to FDA, including opportunities for face-to-face meetings and written consultation throughout the remaining development of paxalisib. Drugs granted FTD may also be eligible for Accelerated Approval and Priority Review, which may result in faster product approval. - Paxalisib was previously granted FTD for glioblastoma in August 2020, giving paxalisib now two largely independent opportunities to access the benefits of this designation. $1.40 has acted as support so far in the pre-market and will be an important level to watch. Above it, targets to the upside are $1.60, with the pre-market high of $1.63 above that. Beyond that, targets are $1.68, $1.80, $1.90 and $2. Below $1.40, there is potential support at $1.31, $1.20 and a gap to fill at $1.17. GENI - Up over 11% in pre after extending partnership with NFL as Exclusive Official Data and Watch & Bet Distribution Partner Genius Sports (GENI) [develops and sells]( technology-led products and services to the sports, sports betting and sports media industries. This morning GENI [announced]( that its exclusive long-term strategic partnership with the NFL now continues through the end of the 2027-28 season. Genius Sports is to remain the exclusive distributor of the NFL’s official live game data and Next Gen Stats (“NGS”) feeds to global media and betting markets The [extended agreement]( also includes exclusive right to distribute digital advertising inventory and marks and logos to global sportsbooks, with an additional agreement extending Genius Sports’ exclusive right to distribute NFL low latency Watch & Bet live game video feeds to U.S. sportsbooks. The stock is up over 11% in pre-market on the news. The $6.30 area has so far acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $6.60, $6.83 and then the pre-market high of $7.84. Beyond that, $8.17, $9 and $10 come into play. Below $6.30, there is potential support at $6.08, $6, and a gap to fill at $5.81. [Economic Calendar]( To Your Success! *please see disclosures below Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions *PAID ADVERTISEMENT. RagingBull has been paid twenty thousand dollars by ach bank transfer by GameSquare for advertising from a period beginning on July 5, 2023 through July 7 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull do not hold a position in GameSquare. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of GameSquare, increased trading volume, and possibly an increased share price of the GameSquare securities, which may or may not be temporary and decrease once the marketing arrangement has ended. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https: // www. sec. gov/edgar/searchedgar/companysearch TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. WE MAY HOLD SECURITIES DISCUSSED. [Ragingbull.com](, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States